September 25, 2023, VANCOUVER, BC – Arbutus Medical Inc., a medical device company developing innovative surgical drill technology and sterile-packed orthopaedic procedure kits, is pleased to announce the appointment of Marie-Claude Jacques to its Board of Directors. Jacques brings more than 15 years of expertise in medical device sales, marketing, and commercial strategy. She joins the company at an exciting time, as Arbutus Medical starts scaling up commercially.
Jacques is currently AVP, Commercialization & Strategy at Boston Scientific Corporation, a Fortune 500 manufacturer of medical devices used in rhythm management, endoscopy, neuromodulation, peripheral interventions, and urology/pelvic health. This role follows a very successful 15 years in sales leadership at Baylis Medical where she was responsible for building and scaling the US business. The strategic plans that Jacques put in place at Baylis Medical allowed the company to have high double-digit sales growth for several years in a row. This, combined with her work in market development, were key to becoming the standard-of-care in left heart access in the US. The company’s success led to the acquisition by Boston Scientific for USD $1.75 Billion in 2022.
Jacques’ addition to Arbutus Medical’s Board strengthens the company’s governance and brings commercial expertise to accelerate growth. Having recently closed a round of financing, and with a year-on-year growth rate over 200%, Arbutus Medical is in a position to rapidly establish a market leadership position in skeletal traction and continue expanding a product portfolio that streamlines orthopaedic surgery for the good of patients worldwide.
“I look forward to working with an amazing team. In a short period of time in the US market, Arbutus has made a meaningful impact in Skeleton Traction and proven itself as the partner of choice for a multitude of institutions. The company’s latest results are impressive. Given the best-in-class products and the leadership team’s passion for helping patients, it is clear that Arbutus has a bright future in streamlining orthopaedic surgery worldwide.”
Jacques is currently a mentor at The Canadian Entrepreneurs in New England (CENE), where influential entrepreneurs leverage their experience to mentor and grow a new generation of successful Canadian-led companies, and at the Canadian Trade Accelerator in Boston/Cambridge, a program funded by Global Affairs Canada of which Arbutus Medical is an alumnus. She is a member of Chief, a private network for senior executive women to strengthen their leadership and influence, and help others do the same. Jacques is also a member of the Cardiology Inclusion Council at Boston Scientific Corporation.
“Working closely with Marie-Claude in an advisory capacity over the past year, it became clear that her experience in scaling a medical device sales organization will help Arbutus Medical scale and create value quickly. We’re thrilled to have her join the Board and look forward to helping millions of patients together.”
About Arbutus Medical Inc.
Arbutus Medical Inc. is a privately held ISO13485/MDSAP-certified medical device company headquartered in Vancouver, Canada. The company develops orthopaedic innovations that streamline surgery for the good of patients. Arbutus Medical is currently focused on improving the standard of care for bedside skeletal traction surgeries in the ER of Trauma Centers through its TrakPak® product line. In addition to TrakPak®, the company distributes a line of surgical drills with DrillCover Technology that are available at accessible price points to customers around the globe. Arbutus Medical’s products have regulatory clearances from the U.S. Food & Drug Administration (FDA) and Health Canada, and have been used by customers in 40 countries, enabling an estimated 100,000 surgeries to date. For more information about Arbutus Medical, visit arbutusmedical.com and follow the company on LinkedIn.